[1]
M. Coppola, MD and R. Mondola, MD, “Potential pharmacological perspectives for the treatment/prevention of the SARS-COV-2 infection in opioid dependent patients”, J of Opioid Management, vol. 16, no. 3, pp. 165–166, May 2020.